The 2026 Regulatory Milestone

In the rapidly evolving landscape of photonic healthcare and aesthetic technology, compliance is the bridge between innovation and market leadership. As we enter 2026, 1ONEVCSEL is proud to announce a pivotal milestone in our global growth strategy: the official roadmap to finalize FDA Class I Component Registration by the end of the second quarter (Q2) of 2026.

This strategic move is designed to empower our OEM and ODM partners. By securing this registration, 1ONEVCSEL simplifies the complex integration path for manufacturers, ensuring that the critical "light engine" of their systems—the VCSEL array—is pre-validated for safety and regulatory consistency.

The 1ONEVCSEL Multi-Wavelength Matrix: Engineering the Future

Modern photonic protocols demand more than just power; they require a sophisticated orchestration of spectral bands. 1ONEVCSEL has expanded its FDA registration scope to include our most advanced Dual, Triple, and Quad-wavelength integrated SMDs.

These configurations are meticulously engineered to support the diverse optical penetration requirements and energy distribution models. Below is our core product portfolio now standardized under the 2026 regulatory roadmap:

1. Specialized Scalp Wellness & Follicle Optical Solutions

For partners developing high-end scalp care systems, we provide the "Golden Wavelength" series, focused on optimized energy delivery to the target dermal layers:

• 678nm VCSEL Laser Diode SMD: The precision-engineered single wavelength for targeted scalp applications.

• 650nm + 808nm Dual-Wavelength VCSEL: Combining rapid surface interaction with deep-reaching 808nm NIR support.

• 650nm + 780nm + 808nm Triple-Wavelength VCSEL: Our advanced cascading energy model for comprehensive follicle-level optical stimulation.

2. Multispectral Aesthetic & Skin-Surface Platforms

To support versatile aesthetic hardware, we have mastered the integration of narrow-band VCSELs with wide-angle high-efficiency LEDs:

• 633nm + 415nm + 830nm/850nm Triple-Wavelength: A sophisticated system designed for multi-layer optical interaction (balancing blue, red, and NIR bands).

• 660nm + 460nm + 1064nm Triple-Wavelength: Extending the spectrum to the deep-infrared for advanced thermal modulation and skin-surface clarity.

• 660nm + 520nm + 940nm Triple-Wavelength: Optimizing irradiance uniformity across the visible and infrared spectrum.

3. High-Density Dual & Quad-Wavelength Arrays

For professional-grade systems requiring maximum fluence and spectral variety in a compact footprint:

• Red + IR Dual-Wavelength (660nm/665nm + 940nm): Our flagship SMD series, balancing the 660nm absorption peak with the deep penetration of 940nm NIR.

• Quad-Wavelength Powerhouse (660nm + 850nm + 940nm + 1064nm): A comprehensive four-band SMD solution that allows for complex, software-controlled pulsing protocols, reaching every critical layer of the tissue matrix.

Engineering Excellence: SMD vs. COB Packaging

To meet the varied demands of industrial-grade hardware, our registration includes two primary packaging architectures:

• SMD (Surface Mount Device): Ideal for high-volume, automated assembly. Our SMD VCSELs offer a compact form factor with integrated Zener diodes for ESD protection, perfect for consumer-grade wearables.

• COB (Chip-on-Board): Designed for high-performance systems. By mounting the VCSEL die directly onto a high-thermal-conductivity substrate, we achieve industry-leading heat management for 808nm and 1064nm power-dense modules.

Streamlining the 510(k) Process with SE Data Support

The path to an FDA 510(k) clearance is often hindered by the lack of detailed component data. 1ONEVCSEL bridges this gap. By choosing our FDA-registered components, our partners gain access to:

1. Substantial Equivalence (SE) Data: We provide the technical dossiers required to prove that your "light engine" meets established safety benchmarks.

2. ISO 13485 Quality Standards: Our manufacturing processes are aligned with medical-grade quality management systems, ensuring batch-to-batch consistency.

3. Comprehensive Optical Characterization: Detailed reports on spectral precision, beam uniformity, and thermal stability that can be directly imported into your regulatory technical files.

Conclusion: Future-Proofing Your Supply Chain

As we look toward Q2 2026, 1ONEVCSEL is not just selling chips; we are providing a compliant, scalable, and technologically advanced foundation for your next-generation products. By integrating our multi-wavelength VCSEL/LED hybrids into your roadmap, you reduce R&D risk and accelerate your time-to-market in the global photonic health sector.